Healt


 Jatcorp (ASX: JAT) reports strong revenue growth in March quarter

Jatcorp (ASX: JAT) reports strong revenue growth in March quarter

April 26, 2022 07:42 PM AEST| By Aditi Sarkar

Highlights The ease in pandemic restrictions has put Jatcorp in an excellent position to reap the benefits of investments made since 2020 The company’s gross revenue for the March quarter increased by 25% and 87% compared to the December...

 Wellfully (ASX:WFL) shares jump 7% on US registration

Wellfully (ASX:WFL) shares jump 7% on US registration

April 26, 2022 12:18 PM AEST| By Aditi Sarkar

Highlights Wellfully has successfully registered its Swisswell Knee Patch™ as a medical device in the US. North America is the world’s largest topical pain relief market, projected to exceed US$9.4 billion in 2026 The development s.....

 PolyNovo (ASX:PNV) charged up on record revenue in March quarter

PolyNovo (ASX:PNV) charged up on record revenue in March quarter

April 06, 2022 06:25 PM AEST| By Sonal Goyal

Highlights PolyNovo has delivered a return of AU$12.26 million in the March quarter. Proceeds for the Lorimer Street property sale is expected in July 2022. PolyNovo’s clinical trial programme is also on track. Shares of PolyNovo Li.....

 ACW, IHL & CGS: ASX healthcare penny stocks with over 150% returns in one year

ACW, IHL & CGS: ASX healthcare penny stocks with over 150% returns in one year

April 06, 2022 02:56 PM AEST| By Aditi Sarkar

Highlights Penny stocks have strong potential to yield lucrative rewards. They are extremely volatile; thus, investors should do proper due diligence. ACW, IHL and CGS are among the penny stocks from the ASX healthcare space that have delivere.....

 4DMedical (ASX:4DX) commences first clinical pilot in the United States 

4DMedical (ASX:4DX) commences first clinical pilot in the United States 

April 06, 2022 02:53 PM AEST| By Aditi Sarkar

Highlights 4D Medical is commercially using its XV LVAS™ technology for the first time in the United States. The pilot program will help open the door to the vast US diagnostics market. Respiratory diagnostics has an annual global indust.....

 MX1, MDR, and OSX: Medical technology stocks from ASX

MX1, MDR, and OSX: Medical technology stocks from ASX

April 06, 2022 12:43 PM AEST| By Aditi Sarkar

Highlights Products, services, and solutions used in the medical field are known as medical technologies Pregnancy tests and X-rays are one of the widely used medical technologies The rapid advancement of technology has resulted in sophisticat.....

 BGH intends to make new Virtus (ASX:VRT) bid at AU$8 cash per share

BGH intends to make new Virtus (ASX:VRT) bid at AU$8 cash per share

April 06, 2022 11:54 AM AEST| By Priyanka Payal

Highlights BGH Capital is considering making an off-market takeover offer to acquire all fully paid ordinary shares (Shares) in Virtus Health Limited at AU$8.00 cash per share. The renewed bid comes after Virtus had already recommended a takeov.....

 All you need to know about the S&P/ASX 200 Health Care

All you need to know about the S&P/ASX 200 Health Care

April 05, 2022 01:58 PM AEST| By Aditi Sarkar

Highlights Indices are benchmark and a standard reference point for the entire stock market Comparison with an index gives an easy assessment of a stock’s performance The S&P/ASX200 index has provided the highest total return in 2012.....

 What about the Cyber Security bill is ailing private hospitals?

What about the Cyber Security bill is ailing private hospitals?

April 04, 2022 12:50 PM AEST| By Aditi Sarkar

Highlights According to the new Cyber Security Bill proposed in Australia, private hospitals with Intensive Care Units must comply with cyber security obligations Private hospitals are having difficulty in complying with new security measures d.....

 Anatara Life Sciences (ASX: ANR) swiftly progresses its clinical trials

Anatara Life Sciences (ASX: ANR) swiftly progresses its clinical trials

April 01, 2022 07:25 PM AEDT| By Aditi Sarkar

Highlights Anatara Lifesciences is advancing well in its clinical trials in psychological functioning and irritable bowel syndrome, diarrhoea subtype (IBS-D) The business prospect for non-prescription gastrointestinal disorders and IBS is US$8 .....

 PCK, LBT, OPL – Three AI stocks from ASX healthcare

PCK, LBT, OPL – Three AI stocks from ASX healthcare

April 01, 2022 05:52 PM AEDT| By Aditi Sarkar

Highlights Integrating AI into medical sector can enhance different processes like medical screenings, diagnosis, and patient data Cardiology, neurology, and cancer are the major diseases that utilise AI tools AI delivers data for diagnosis, t.....

 How have REG, CSL share prices fared after budget’s healthcare boost?

How have REG, CSL share prices fared after budget’s healthcare boost?

March 31, 2022 11:22 AM AEDT| By Ashish

Highlights ASX-listed healthcare stocks have gained after the budget presentation. The stocks received a significant boost from extra spending on Medicare announced in the budget. The Australian Federal Budget was tabled on 29 March...

 Polynovo (ASX:PNV) shows uptrend after shedding 58% in a year

Polynovo (ASX:PNV) shows uptrend after shedding 58% in a year

March 30, 2022 04:25 PM AEDT| By Samta

Highlights Polynovo shares have been gaining attention despite no new announcement. The stock that dropped over 58% in the last 12 months, has been displaying an upward momentum this week. PNV's second quarter US sales grew 105% on pcp in the .....

 Living Cell (ASX:LCT) surges over 14% on clinical trial for Parkinson's disease

Living Cell (ASX:LCT) surges over 14% on clinical trial for Parkinson's disease

March 30, 2022 03:38 PM AEDT| By Aditi Saha

Highlights LCT has inked a deal with University of Technology to utilise university facilities in Sydney. NTCELL capsules will be manufactured in Australia for the first time, progressing the third clinical trial of NTCELL in Parkinson’s .....

 Recce Pharmaceuticals (ASX:RCE) shares encouraging trial data for next-gen antibiotic 

Recce Pharmaceuticals (ASX:RCE) shares encouraging trial data for next-gen antibiotic 

March 30, 2022 02:19 PM AEDT| By Aditi Sarkar

Highlights Recce Pharmaceuticals’ R327 exhibits a safe and tolerable profile. The safety profile of R327 at a twenty-fold increase of the initial dosing level is crucial for synergies across the company’s wider-infectious disease po.....

 Telix (ASX:TLX) shares jump on receiving an FDA approval

Telix (ASX:TLX) shares jump on receiving an FDA approval

March 29, 2022 07:08 PM AEDT| By Aditi Saha

Highlights Telix has been granted an FDA approval for Orphan Drug Designation for bone marrow conditioning treatment. Telix is a biopharmaceutical business specialising in commercialising and producing therapeutic and diagnostic products. The .....

 From IMC to ALA: Healthcare stocks with best YTD returns

From IMC to ALA: Healthcare stocks with best YTD returns

March 28, 2022 03:54 PM AEDT| By Aditi Sarkar

Highlights The Australian healthcare sector includes companies engaged in biotechnology and research, food and drug retailing, health care equipment, service providers, and pharmaceuticals. On a YTD basis, the healthcare index is running low at.....

 OncoSil Medical (ASX:OSL) shares jump 14% on G-BA approval

OncoSil Medical (ASX:OSL) shares jump 14% on G-BA approval

March 28, 2022 01:30 PM AEDT| By Aditi Sarkar

Highlights OncoSil Medical has secured G-BA approval for a fully funded trial to evaluate its OncoSil device.   Successful results from the clinical trial are anticipated to lead to public insurance reimbursement funding of the device.....

 CapVest Partners gets approval from FIRB to takeover Virtus Health (ASX:VRT)

CapVest Partners gets approval from FIRB to takeover Virtus Health (ASX:VRT)

March 25, 2022 08:52 PM AEDT| By Aditi Saha

Highlights CapVest Partners has received confirmation from FIRB to buy Virtus Health. This follows an announcement by the company on 14 March 2022. Virtus Health Limited specialises in the business of fertility, medical day procedures, and med.....

 Incannex (ASX: IHL) signs term sheet to snap up APIRx Pharmaceutical USA

Incannex (ASX: IHL) signs term sheet to snap up APIRx Pharmaceutical USA

March 24, 2022 05:34 PM AEDT| By Aditi Sarkar

A clinical-stage pharmaceutical company, Incannex Healthcare Limited (ASX: IHL) (Nasdaq: IXHL) has executed a term sheet with binding commercial terms to wholly acquire APIRx Pharmaceutical USA, LLC ('APIRx'). The proposed acquisition price is US$9.....

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.